National Health Investors, Inc. (NHI) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$73.09
Price Target
$85.40
Target Range
$83.00 — $88.00
Analyst Rating
Hold
Forward P/E21.6x
Trailing P/E24.2x
Forward PEG—
Implied Growth+11.1%
Median Target$85.00
Analyst Spread5.9%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$83
+13.6%
Consensus
$85
+16.8%
Bull Case
$88
+20.4%
Valuation Model TargetsConfidence: 51/100
Bear$51
Base$81
Bull$111
NHI Price Target Analysis
Updated May 6, 2026As of May 6, 2026, National Health Investors, Inc. (NHI) has a Wall Street consensus price target of $85.40, based on estimates from 18 covering analysts. With the stock currently trading at $73.09, this represents a potential upside of +16.8%. The company has a market capitalization of $3.54B.
Analyst price targets range from a low of $83.00 to a high of $88.00, representing a 6% spread in expectations. The median target of $85.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 6 analysts rating the stock as a Buy or Strong Buy,11 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, NHI trades at a trailing P/E of 24.2x and forward P/E of 21.6x. Analysts expect EPS to grow +11.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $80.93, with bear and bull scenarios of $51.06 and $110.85 respectively. Model confidence stands at 51/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Real Estate stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+2.9%
Avg Forward P/E114.0x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 OHIOmega Healthcare Investors, Inc. | $13.7B | $46.12 | $49.14 | +6.5% | Hold | 23.4x | 28 |
 SBRASabra Health Care REIT, Inc. | $5.1B | $20.38 | $21.20 | +4.0% | Hold | 29.5x | 29 |
 LTCLTC Properties, Inc. | $1.9B | $38.20 | $36.00 | -5.8% | Hold | 19.7x | 22 |
 CTRECareTrust REIT, Inc. | $8.8B | $39.34 | $42.50 | +8.0% | Buy | 26.5x | 19 |
 GMREGlobal Medical REIT Inc. | $94M | $35.74 | $40.00 | +11.9% | Buy | 595.7x | 22 |
 VTRVentas, Inc. | $41.3B | $86.78 | $90.80 | +4.6% | Buy | 118.3x | 32 |
 WELLWelltower Inc. | $150.1B | $214.30 | $226.50 | +5.7% | Buy | 78.9x | 34 |
 HRHealthcare Realty Trust Incorporated | $6.9B | $19.92 | $19.33 | -3.0% | Hold | — | 29 |
 DOCHealthpeak Properties, Inc. | $11.5B | $16.51 | $17.86 | +8.2% | Buy | 84.8x | 40 |
 MPWMedical Properties Trust, Inc. | $3.4B | $5.65 | $5.00 | -11.5% | Hold | 49.4x | 28 |
Upside Potential Comparison
GMREDOCCTREOHIWELLVTRSBRAHRSee NHI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NHI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NHI vs WELL
Side-by-side business, growth, and profitability comparison vs Welltower Inc..
Start ComparisonNHI — Frequently Asked Questions
Quick answers to the most common questions about buying NHI stock.
What is the NHI stock price target for 2026?
National Health Investors, Inc. (NHI) has a consensus 12-month price target of $85.4, implying 16.8% upside from $73.09. The 18 analysts covering NHI see moderate appreciation potential.
Is NHI a buy, sell, or hold?
NHI has a consensus rating of "Hold" based on 18 Wall Street analysts. The rating breakdown is mixed, with 11 Hold ratings making up the largest segment. The consensus 12-month price target of $85.4 implies 16.8% upside from current levels.
Is NHI stock overvalued or undervalued?
NHI trades at a forward P/E of 21.5834x, representing a moderate valuation. With analysts targeting $85.4 (16.8% implied move), the stock appears reasonably valued with upside.
How high can NHI stock go?
The most bullish Wall Street analyst has a price target of $88 for NHI, while the most conservative target is $83. The consensus of $85.4 represents the median expectation. Our quantitative valuation model projects a bull case target of $111 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover NHI stock?
NHI is well covered by analysts, with 18 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 11 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the NHI stock forecast?
The 12-month NHI stock forecast based on 18 Wall Street analysts shows a consensus price target of $85.4, with estimates ranging from $83 (bear case) to $88 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $81, with bear/bull scenarios of $51/$111.
What is NHI's fair value based on fundamentals?
Our quantitative valuation model calculates NHI's fair value at $81 (base case), with a bear case of $51 and bull case of $111. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 51/100.
What is NHI's forward P/E ratio?
NHI trades at a forward P/E ratio of 21.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 24.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy NHI stock?
Wall Street analysts are optimistic on NHI, with a "Hold" consensus rating and $85.4 price target (16.8% upside). 6 of 18 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do NHI price targets vary so much?
NHI analyst price targets range from $83 to $88, a 6% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $85.4 consensus represents the middle ground. Our model's $51-$111 range provides an independent fundamental perspective.